Teva Pharmaceuticals' Stocks Jump After 2Q, Allergan Update

Jul 13, 2016

The Street

Shares of Teva Pharmaceuticals are up 7.03% to $56.15 at the start of trading on Wednesday, according to an article in The Street, after increasing its second-quarter forecast and promoting its Allergan deal is on schedule and could close any day now.

Teva now anticipates second-quarter revenues between $4.9 billion and $5 billion vs. past estimates between $4.8 billion and $4.9 billion. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments